From Five Products to a 12-Product Portfolio: How YOGARVEDA Is Expanding Its Ayurvedic Wellness Proposition
The Mumbai-based brand has added seven products in FY 2026–27, moving beyond its original Shilajit and personal-care portfolio into multiple areas of everyday wellness
Mumbai, October 2026: For a young Ayurvedic wellness company, product expansion is not simply about increasing the number of SKUs. It is also about deciding which consumer needs a brand wants to address.
For YOGARVEDA Lifescience LLP, that evolution has taken place in a relatively short period. The company entered the market in 2025 with five products. During FY 2026–27, it added seven more, taking its portfolio to 12 products and expanding into several new areas of wellness.
The development reflects a broader strategy: build an Ayurvedic wellness brand that goes beyond a single ingredient or category and offers consumers a wider range of products for different lifestyle and wellness requirements.
A five-product beginning
YOGARVEDA began its product journey in 2025 with five products: Shilajit Gummies, Shilajit Resin, Aloe Vera Gel, Rose Water and Vitamin C Face Serum.
The initial portfolio brought together two distinct elements.
The first was Ayurvedic and herbal wellness, represented particularly by the Shilajit products. The second was herbal personal care, represented by Aloe Vera Gel, Rose Water and Vitamin C Face Serum.
Even at this early stage, the portfolio was not built around a single product format. Gummies, resin, gel, spray and serum provided different ways for consumers to engage with the brand.
That foundation subsequently allowed YOGARVEDA to move into a wider range of wellness categories.
2026: the portfolio begins to change
The first stage of the 2026 expansion came in June, when the company introduced Ortho Max Tablets and Cough & Throat Care Syrup.
Ortho Max marked an entry into physical and mobility-oriented wellness, while Cough & Throat Care Syrup introduced a product focused on cough and throat care.
These two products were followed by a significantly larger October launch.
In October 2026, YOGARVEDA introduced five additional formulations:
Slim Fit Tablets, Power Play Tablets, Sleep Fast Tablets, Diabecare Tablets and Women’s Care Tablets.
Together, the seven launches transformed the company’s portfolio from a relatively focused five-product range into a multi-category wellness offering.
Five October launches, five distinct consumer propositions
The October expansion is particularly notable because each product addresses a different area of wellness.
Slim Fit: wellness around healthy lifestyle management
YOGARVEDA Slim Fit Tablets are positioned around healthy weight management, metabolism and digestive wellness.
The formulation combines botanical ingredients traditionally used in Ayurveda, including Guggul, Triphala, Musta, Punarnava, Vidanga, Chitrak, Vijaysar, Fenugreek, Ajwain and Pippali.
The product is positioned as part of a broader healthy-lifestyle approach rather than as a quick-fix weight-loss proposition.
Power Play: men’s vitality and physical wellness
YOGARVEDA Power Play Tablets give the company a dedicated men’s wellness offering.
The formulation includes ingredients such as Ashwagandha, Kapikacchu, Shweta Musli, Safed Musli, Gokshura, Shilajit and Akarkara.
Its positioning centres on men’s vitality, energy, stamina, strength, endurance and overall wellness.
This places the product within the increasingly diverse men’s wellness category while retaining an Ayurvedic formulation identity.
Sleep Fast: wellness through better rest
With Sleep Fast Tablets, YOGARVEDA has entered the sleep and relaxation segment.
The formulation includes Tagar, Jatamansi, Brahmi, Shankhpushpi, Ashwagandha and Khus, among other botanical ingredients.
The product is positioned around restful sleep, relaxation, mental calmness and a healthy sleep routine.
Its inclusion is consistent with a broader understanding of wellness in which sleep and recovery are increasingly considered important parts of everyday wellbeing.
Diabecare: a metabolic-wellness proposition
Diabecare Tablets represent YOGARVEDA’s move into metabolic wellness.
The formulation combines botanical extracts including Gudmar, Karela, Vijaysar, Jamun, Guduchi, Fenugreek, Daruharidra, Amla, Neem, Haridra and Pippali.
The product is positioned around healthy glucose metabolism, metabolic balance and blood-sugar support.
Because products associated with metabolic health operate in a highly sensitive regulatory environment, YOGARVEDA’s public positioning needs to remain focused on wellness support rather than presenting the product as a treatment or cure for a disease.
Women’s Care: dedicated women’s wellness
YOGARVEDA Women’s Care Tablets add another important dimension to the portfolio by creating a dedicated women’s wellness proposition.
The formulation includes botanicals such as Shatavari, Ashoka, Lodhra, Kumari, Ashwagandha, Guduchi, Amla, Nagkesar, Punarnava, Jeevanti, Haridra, Tulsi and Pippali.
The product is positioned around women’s overall wellness, vitality and menstrual-health support.
The launch allows YOGARVEDA to address women’s wellness as a dedicated category rather than treating it as a secondary part of a general wellness portfolio.
The importance of the seven-product expansion
Viewed individually, the seven products represent different wellness propositions.
Viewed together, however, they reveal something more significant about YOGARVEDA’s strategy.
The company is moving towards a portfolio model.
Instead of building its identity around one hero ingredient, YOGARVEDA now has products spanning:
- Traditional Shilajit wellness
- Herbal personal care
- Physical and mobility wellness
- Cough and throat care
- Healthy weight management
- Men’s vitality
- Sleep and relaxation
- Metabolic wellness
- Women’s wellness
This creates a much broader foundation for distribution, retail presence and consumer engagement.
Ayurveda with a contemporary product strategy
YOGARVEDA’s portfolio also reflects the changing formats through which consumers encounter Ayurvedic and herbal products.
The company’s 12 products include tablets, gummies, syrup, resin, gel, spray and serum.
The objective is to retain the association with traditional Ayurvedic and botanical ingredients while presenting products in formats that are familiar and convenient for today’s consumers.
This is increasingly relevant as younger consumers in particular become interested in traditional Indian wellness while simultaneously expecting modern packaging, convenient formats and clearly defined product purposes.
Quality and manufacturing
The company’s expansion is supported by a stated emphasis on quality systems and manufacturing standards.
YOGARVEDA has Startup India recognition, ISO 9001:2015 certification and HACCP certification. It operates as a brand owner and marketer and works with specialised third-party manufacturing partners.
This model allows the company to focus on product development, formulation specifications, quality requirements, branding and market expansion while production is undertaken through specialised manufacturing partners.
YOGARVEDA’s website states that its products are manufactured through facilities associated with WHO-GMP, FSSAI and AYUSH approvals, subject to the applicable product and manufacturing facility.
From product launch to portfolio strategy
The significance of YOGARVEDA’s expansion is therefore not limited to the addition of seven products.
The company’s product strategy has evolved.
In 2025, the focus was on establishing the brand with five products across Ayurvedic wellness and herbal personal care.
In 2026, the focus shifted towards portfolio diversification.
Two products were added in June, followed by five in October, taking the total to 12.
That progression gives YOGARVEDA a substantially wider base from which to develop its distribution network and establish the brand across multiple consumer wellness categories.
The next chapter
The next challenge for YOGARVEDA will be to translate portfolio expansion into wider consumer reach.
The company is developing online and offline distribution, including distributor and retail relationships, while continuing to build its brand in India’s competitive wellness market.
For the company, the seven FY 2026–27 launches are therefore not simply new additions to a catalogue. They represent the next stage of an effort to establish YOGARVEDA as a multi-category Indian Ayurvedic wellness brand.
From five products in 2025 to 12 products in 2026, the trajectory points towards a company attempting to build breadth while retaining a clear connection to Ayurveda.
As the Indian wellness market continues to mature, YOGARVEDA’s expansion illustrates one approach emerging brands are taking: preserve the foundation of traditional wellness, but broaden the formats, categories and consumer propositions through which that tradition reaches the modern market.
About YOGARVEDA Lifescience LLP
YOGARVEDA Lifescience LLP is an Indian Ayurvedic and wellness company offering products across Ayurvedic wellness, herbal personal care and lifestyle-oriented wellness categories. The company began its product journey in 2025 with five products and expanded its portfolio to 12 products during FY 2026–27. YOGARVEDA states that it has Startup India recognition, ISO 9001:2015 and HACCP certifications and works with specialised third-party manufacturing partners.
YOGARVEDA™ — Ancient Ayurveda, Modern Vitality.
